Literature DB >> 19232169

[Negative predictive value of (123)I Ioflupane SPECT in movement disorders].

J Serrano Vicente1, L García Bernardo, C Durán Barquero, A Constantino Silva, J R Infante de la Torre, M L Domínguez Grande, J I Rayo Madrid, R Sánchez Sánchez, C Durán Herrera.   

Abstract

OBJECTIVE: A non-degenerative etiology is supported by a normal SPI [normal SPECT with 123I-Ioflupane (SPI)] in a patient with movement disorders (MD).
METHOD: A total of 196 SPIs were conducted during the period of 2004/05. Of these, 44 were selected in order to rule out degenerative MD (DMD), the results being normal in these patients. The clinical background of these patients were reviewed in a minimum period of 24 months (range 24-40), collecting the diagnoses reached by the neurology specialists. The SPI were evaluated using a consensus, according to subjective criteria and quantification.
RESULTS: Thirty-six of the 44 patients (81%) were identified at 2 years of having nondegenerative movement disorders: 18 as essential tremor, 5 as drug-induced disorder, 4 as vascular disease, 3 as peripheral polyneuropathy, 2 postural tremors, 1 writer's cramp, 1 psychogenic tremor, 1 intercranial hypertension and 1 fibromyalgia. The remaining 8 patients were diagnosed with Parkinson's disease in 5 cases, 1 corticobasal degeneration, 1 multisystemic atrophy and another degenerative Parkinsonism with unclear etiology.
CONCLUSION: The SPI in our hospital has a lower negative predictive value than the data reported in the literature. The false negatives could be explained because most of our patients come from neurologist physicians who are not movement disorder experts. In addition, a small proportion of degenerative Parkinsonism could evolve with normal SPI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232169

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  3 in total

1.  Expert testimony at the Food and Drug Administration: who wants the truth?

Authors:  Joel S Perlmutter
Journal:  Narrat Inq Bioeth       Date:  2011

Review 2.  Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT.

Authors:  Balestrino Roberta; Barone Paolo; Filippi Massimo; Erro Roberto
Journal:  J Neurol       Date:  2021-09-18       Impact factor: 6.682

3.  Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study.

Authors:  Manuel Menéndez-González; Francisco Tavares; Nahla Zeidan; José M Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Aging Neurosci       Date:  2014-04-01       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.